Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Med Virol ; 96(4): e29555, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38546037

RESUMO

In this study, we demonstrated the antiviral efficacy of hesperetin against multiple poxviruses, including buffalopox virus (BPXV), vaccinia virus (VACV), and lumpy skin disease virus (LSDV). The time-of-addition and virus step-specific assays indicated that hesperetin reduces the levels of viral DNA, mRNA, and proteins in the target cells. Further, by immunoprecipitation (IP) of the viral RNA from BPXV-infected Vero cells and a cell-free RNA-IP assay, we demonstrated that hesperetin-induced reduction in BPXV protein synthesis is also consistent with diminished interaction between eukaryotic translation initiation factor eIF4E and the 5' cap of viral mRNA. Molecular docking and MD simulation studies were also consistent with the binding of hesperetin to the cap-binding pocket of eIF4E, adopting a conformation similar to m7GTP binding. Furthermore, in a BPXV egg infection model, hesperetin was shown to suppress the development of pock lesions on the chorioallantoic membrane and associated mortality in the chicken embryos. Most importantly, long-term culture of BPXV in the presence of hesperetin did not induce the generation of drug-resistant viral mutants. In conclusion, we, for the first time, demonstrated the antiviral activity of hesperetin against multiple poxviruses, besides providing some insights into its potential mechanisms of action.


Assuntos
Fator de Iniciação 4E em Eucariotos , Hesperidina , Vaccinia virus , Animais , Bovinos , Chlorocebus aethiops , Embrião de Galinha , Células Vero , Simulação de Acoplamento Molecular , Vaccinia virus/genética , Antivirais/farmacologia , RNA Mensageiro , Replicação Viral
2.
FEBS Lett ; 587(24): 3928-34, 2013 Dec 11.
Artigo em Inglês | MEDLINE | ID: mdl-24211447

RESUMO

Initiation is the rate-limiting step during mRNA 5' cap-dependent translation, and thus a target of a strict control in the eukaryotic cell. It is shown here by analytical ultracentrifugation and fluorescence spectroscopy that the affinity of the human translation inhibitor, eIF4E-binding protein (4E-BP1), to the translation initiation factor 4E is significantly higher when eIF4E is bound to the cap. The 4E-BP1 binding stabilizes the active eIF4E conformation and, on the other hand, can facilitate dissociation of eIF4E from the cap. These findings reveal the particular allosteric effects forming a thermodynamic cycle for the cooperative regulation of the translation initiation inhibition.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Fator de Iniciação 4E em Eucariotos/metabolismo , Iniciação Traducional da Cadeia Peptídica/fisiologia , Fosfoproteínas/metabolismo , Multimerização Proteica/fisiologia , Capuzes de RNA/metabolismo , Proteínas Adaptadoras de Transdução de Sinal/química , Proteínas de Ciclo Celular , Fator de Iniciação 4E em Eucariotos/química , Fatores de Iniciação em Eucariotos/química , Fatores de Iniciação em Eucariotos/metabolismo , Fracionamento por Campo e Fluxo , Humanos , Modelos Biológicos , Complexos Multiproteicos/química , Complexos Multiproteicos/metabolismo , Fosfoproteínas/química , Ligação Proteica/fisiologia , Conformação Proteica , RNA Mensageiro/química , RNA Mensageiro/metabolismo , Ultracentrifugação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA